It can promote the progression of prostate diseases through multiple mechanisms, including the induction of DNA damage, activation of inflammatory signaling pathways, disruption of the balance between cell proliferation and apoptosis, and regulation of the HIF-1α-mediated hypoxia response and the NF-κB-driven inflammation-tumor signaling axis. The gene discussed is NFKB1; the disease is neoplasm.